Counselors in Palmyra, VA Accepting Medicare

5 Counselors found. Showing 1 - 5

Mark Hineline Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 13623 James Madison Hwy, Palmyra, VA 22963 Phone: 434-589-8276

Aisha Nicole Williams-cusano, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 13623 James Madison Hwy, Palmyra, VA 22963 Phone: 434-589-8276    Fax: 434-589-2690

Megan Osburn, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 51 Laguna Rd, Palmyra, VA 22963 Phone: 434-644-1640

James E Moyer, L.P.C. Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 13683 James Madison Hwy, Palmyra, VA 22963 Phone: 434-962-9347

Dr. Karena Heyward Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 55 Lafayette Dr, Palmyra, VA 22963 Phone: 804-926-7526

News Archive

FDA accepts Eisai's sNDA for perampanel drug for treatment of PGTC seizures

Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted for review the company's Supplemental New Drug Application (sNDA) for its in-house-discovered AMPA receptor antagonist perampanel for the treatment of primary generalized tonic-clonic (PGTC) seizures.

Toshiba's Aquilion Premium multi-detector CT installed at PinnacleHealth

Leading hospitals require premium diagnostic imaging equipment to image patients faster, with the best possible diagnostic accuracy. PinnacleHealth, a leading health care system in Harrisburg, Pa., has installed Toshiba America Medical Systems, Inc.'s Aquilion® Premium multi-detector CT at its Community Campus to enable them to meet these needs while improving patient care. The Aquilion Premium features 160 detector rows to image up to eight cm of anatomy in a single gantry rotation (as fast as 0.35 seconds).

Researchers seek to shed light on link between ACL and osteoarthritis

Every year, about 250,000 people in the U.S. sustain injuries to the anterior cruciate ligament (ACL), and about half of these individuals end up having reconstructive surgery.

FDA accepts for review BioMimetic Therapeutics' Augment Bone Graft PMA application

BioMimetic Therapeutics, Inc. today announced the Food & Drug Administration (FDA) has accepted for review its Premarket Approval (PMA) application for Augment™ Bone Graft for use in foot and ankle fusions in the U.S. The FDA has now filed the application and begun the comprehensive review of the clinical module.

MetLife announces new DHMO MET Series of Copay plans

MetLife, providing dental plan administration for over 20 million people, today announced its new Dental Health Maintenance Organization (DHMO) MET Series of Copay plans.

Read more Medical News

› Verified 5 days ago